0000930413-11-005004.txt : 20110801 0000930413-11-005004.hdr.sgml : 20110801 20110801112436 ACCESSION NUMBER: 0000930413-11-005004 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110720 FILED AS OF DATE: 20110801 DATE AS OF CHANGE: 20110801 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rackear Andrew D. CENTRAL INDEX KEY: 0001408617 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12957 FILM NUMBER: 11999570 MAIL ADDRESS: STREET 1: 550 HILLS DRIVE STREET 2: 3RD FLOOR CITY: BEDMINSTER STATE: NJ ZIP: 07921 FORMER NAME: FORMER CONFORMED NAME: Rackear Andrew D DATE OF NAME CHANGE: 20070801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENZON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000727510 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 222372868 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 20 KINGSBRIDGE ROAD STREET 2: ATT: GENERAL COUNSEL CITY: PISCATAWAY STATE: NJ ZIP: 08854 BUSINESS PHONE: 732-980-4500 MAIL ADDRESS: STREET 1: 20 KINGSBRIDGE ROAD STREET 2: ATT: GENERAL COUNSEL CITY: PISCATAWAY STATE: NJ ZIP: 08854 FORMER COMPANY: FORMER CONFORMED NAME: ENZON PHARMACEUTICALS INC DATE OF NAME CHANGE: 20021211 FORMER COMPANY: FORMER CONFORMED NAME: ENZON PHARMACEUTICAL INC DATE OF NAME CHANGE: 20021210 FORMER COMPANY: FORMER CONFORMED NAME: ENZON INC DATE OF NAME CHANGE: 19920703 3 1 c66452.xml X0204 3 2011-07-20 0 0000727510 ENZON PHARMACEUTICALS INC ENZN 0001408617 Rackear Andrew D. C/O ENZON PHARMACEUTICALS, INC. 20 KINGSBRIDGE ROAD PISCATAWAY NJ 08854 0 1 0 0 VP and General Counsel Common Stock 44167 D Includes 15,000 Restricted Stock Units granted by the Issuer pursuant to its 2011 Stock Option and Incentive Plan, qualified under Rule 16b-3(d), and vesting in full on May 11, 2014, if the Reporting Person remains employed by the Issuer on such date; and 29,167 Restricted Stock Units granted by the Issuer pursuant to its 2001 Incentive Stock Plan, qualified under Rule 16b-3(d), and vesting in full on September 22, 2013, if the Reporting Person remains employed by the Issuer on such date. The Restricted Stock Units do not have an expiration date, and each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's Common Stock. /s/ Andrew Rackear 2011-08-01